Initial Testing for Cushing Syndrome
The overnight 1-mg Dexamethasone Suppression Test (DST) is recommended as the initial screening test for diagnosing Cushing syndrome, according to the Endocrine Society guidelines. 1
First-Line Diagnostic Tests
The Endocrine Society recommends the following initial tests for screening patients with suspected Cushing syndrome:
Overnight 1-mg Dexamethasone Suppression Test (DST)
- Procedure: 1 mg dexamethasone administered at 11 PM, with cortisol measured at 8 AM the next day
- Interpretation: Failure to suppress morning cortisol suggests Cushing syndrome
- Best used for: Initial screening, evaluation of adrenal incidentalomas, and patients with disrupted circadian rhythms 1
Late-Night Salivary Cortisol (LNSC)
- Sensitivity: >90%, Specificity: 100%
- Particularly useful for: Initial screening and longitudinal surveillance of cyclic Cushing syndrome 1
24-hour Urinary Free Cortisol (UFC)
- Used to support diagnosis and reflect overall cortisol production 1
Test Selection Algorithm
- Start with overnight 1-mg DST as the initial screening test
- Consider adding LNSC if there is suspicion of cyclic Cushing syndrome
- Use 24-hour UFC as a supporting diagnostic test
- Measure plasma ACTH to differentiate between ACTH-dependent and ACTH-independent causes once hypercortisolism is confirmed 1
Important Considerations and Pitfalls
Test Limitations: The standard 1-mg overnight DST may have reduced sensitivity in patients with mild and/or episodic hypercortisolism. Studies have shown that many patients with mild Cushing syndrome can suppress to overnight dexamethasone, potentially leading to false negatives 2
Improved Specificity: Measuring serum dexamethasone levels simultaneously with cortisol can improve test specificity. The lower limit of normal for dexamethasone is 1.8 ng/mL 1
Alternative Approaches: Some research suggests that a lower dose (0.5 mg) DST may provide better sensitivity and specificity (99.1% and 98.4% respectively) with a cortisol cut-off of 3.05 μg/dL 3
Medication Interference: Women on estrogen-containing oral contraceptives may have false positive results when undergoing the 1-mg DST due to estrogen's effect on dexamethasone metabolism 1
Pediatric Considerations: In children, Cushing's disease accounts for 75-80% of cases in those over age 6, while adrenal causes are more common in younger children. Unexplained weight gain combined with growth failure is a key indicator 1
Next Steps After Initial Testing
If the initial screening test is positive:
- Confirm hypercortisolism with additional tests (LNSC or 24-hour UFC)
- Measure plasma ACTH to differentiate between ACTH-dependent and ACTH-independent causes
- Proceed with appropriate imaging studies based on ACTH status
- Consider bilateral inferior petrosal sinus sampling (IPSS) for ACTH-dependent cases with equivocal results 1
Remember that no single test is perfect for diagnosing Cushing syndrome, especially in mild or cyclic cases. The overnight 1-mg DST remains the recommended initial test, but clinicians should maintain a high index of suspicion and follow up with additional testing when clinical features strongly suggest Cushing syndrome despite a negative initial test.